Searched for
PRIYAVRAT BHARTIA
Buy Jubilant Ingrevia, target price Rs 475: Axis SecuritiesJubilant Ingrevia, incorporated in the year 2019, is a Small Cap company (having a market cap of Rs 6768.65 Crore) operating in Chemicals s...- Jubilant Pharmova announces leadership changes; Priyavrat Bhartia takes over as MDJubilant Pharmova Ltd on Tuesday announced leadership changes and board composition with Priyavrat Bhartia being appointed as Managing Dire...
- Buy Jubilant Ingrevia, target price Rs 593: HDFC SecuritiesStock price has been in an uptrend as per the positive chart pattern like higher tops and bottoms.
- Buy Jubilant Pharmova, target price Rs 475: Anand RathiJubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceutica...
- Buy Jubilant Ingrevia, target price Rs 860: Prabhudas LilladherFor the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 1175.90 crore, down 9.89 per cent from last...
- Buy Jubilant Life Sciences, price target Rs 580: Kunal BothraThe analyst suggested a stoploss at Rs 537 .
- Buy Jubilant Life Sciences, price target Rs 575: Kunal BothraThe analyst suggested a stoploss at Rs 533.
- Neutral Jubilant Life Sciences, target Rs 905: Motilal Oswal SecuritiesMotilal Oswal Securities is neutral Jubilant Life Sciences at a price target of Rs 905. The time period given to achieve the target is a qu...
- Jubilant Life appoints Priyavrat Bhartia, Arjun Shanker as directorsPriyavrat Bhartia is the son of Chairman Shyam S Bhartia while Arjun Shanker Bhartia is the son of co-Chairman and Managing Director Hari S...
- Bhartia puts shine on 'paper chase'Shobhana Bhartia has barely time to catch her breath and chat over a cup of coffee with ET.
- Hormusji new INS presidentHormusji N. Cama of Bombay Samachar Weekly, Mumbai has been elected the new president of INS (Indian Newspaper Society) for the year 2006-0...
Load More
